Defining the Sympathetic Skin Response of Migraineurs in the Facial Area
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03772860 |
|
Recruitment Status : Unknown
Verified December 2018 by Hillel Yaffe Medical Center.
Recruitment status was: Not yet recruiting
First Posted : December 11, 2018
Last Update Posted : December 11, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Migraine Disorders | Other: Pain stimulation Other: Visual stimulation Other: Auditory stimulation Other: Mental stress |
| Study Type : | Observational |
| Estimated Enrollment : | 70 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | Defining the Sympathetic Skin Response of Migraineurs in the Facial Area During the Interictal State: Comparison of Migraine Patients Who Suffer Dominant Left/Right/Bilateral Pain. |
| Estimated Study Start Date : | December 2018 |
| Estimated Primary Completion Date : | December 2019 |
| Estimated Study Completion Date : | December 2019 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
Healthy volunteers
Healthy volunteers will be exposed to pain stimulation, visual stimulation, auditory stimulation and mental stress
|
Other: Pain stimulation
Pain will be simulated with an electric shock 25 mlAMP over the median nerve Other: Visual stimulation Visual stimulation will be performed by a flicker of light on a computer screen at 15 Hrz for 0.3 seconds Other: Auditory stimulation Auditory stimulation will be delivered through headphones with a sound at 500 Hrz at 85 decibels for 0.3 seconds Other: Mental stress A mathematical challenge will be displayed on a computer screen that must be quickly solved |
|
Left headache
Migraine patients with mostly left sided headache will be exposed to pain stimulation, visual stimulation, auditory stimulation and mental stress
|
Other: Pain stimulation
Pain will be simulated with an electric shock 25 mlAMP over the median nerve Other: Visual stimulation Visual stimulation will be performed by a flicker of light on a computer screen at 15 Hrz for 0.3 seconds Other: Auditory stimulation Auditory stimulation will be delivered through headphones with a sound at 500 Hrz at 85 decibels for 0.3 seconds Other: Mental stress A mathematical challenge will be displayed on a computer screen that must be quickly solved |
|
Right headache
Migraine patients with mostly right sided headache will be exposed to pain stimulation, visual stimulation, auditory stimulation and mental stress
|
Other: Pain stimulation
Pain will be simulated with an electric shock 25 mlAMP over the median nerve Other: Visual stimulation Visual stimulation will be performed by a flicker of light on a computer screen at 15 Hrz for 0.3 seconds Other: Auditory stimulation Auditory stimulation will be delivered through headphones with a sound at 500 Hrz at 85 decibels for 0.3 seconds Other: Mental stress A mathematical challenge will be displayed on a computer screen that must be quickly solved |
|
Bilateral headache
Migraine patients without a dominant side headache will be exposed to pain stimulation, visual stimulation, auditory stimulation and mental stress
|
Other: Pain stimulation
Pain will be simulated with an electric shock 25 mlAMP over the median nerve Other: Visual stimulation Visual stimulation will be performed by a flicker of light on a computer screen at 15 Hrz for 0.3 seconds Other: Auditory stimulation Auditory stimulation will be delivered through headphones with a sound at 500 Hrz at 85 decibels for 0.3 seconds Other: Mental stress A mathematical challenge will be displayed on a computer screen that must be quickly solved |
- Defining sympathetic skin response in migraineurs [ Time Frame: One year ]Outcome will be presented as mean sympathetic response values for all the different stimuli and then separately for each stimuli
- Defining differences between sympathetic skin response in migraineurs [ Time Frame: One year ]Outcome will be presented as mean sympathetic response values for all the different stimuli and then separately for each stimuli
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Healthy volunteers with no history of any kind of recurrent headache
- Migraine patients according to ICH3 criteria
- Migraine patients with more than 1 attack per month
Exclusion Criteria:
- Patients with other heart or neurologic diseases
- Patients with hearing or visual decline
- Patients taking medication that effects the sympathetic system (except those taking beta blockers for migraine treatment)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03772860
| Contact: Erel Domany, MD | 972-52-6134235 | erel.domany@gmail.com |
| Israel | |
| Hillel Yaffe Medical Center | |
| Hadera, Israel, 38100 | |
| Contact: Erel Domany, MD erel.domany@gmail.com | |
| Study Director: | Yaron River, MD | Hillel Yaffe Medical Center |
| Responsible Party: | Hillel Yaffe Medical Center |
| ClinicalTrials.gov Identifier: | NCT03772860 |
| Other Study ID Numbers: |
HYMC-113-18 |
| First Posted: | December 11, 2018 Key Record Dates |
| Last Update Posted: | December 11, 2018 |
| Last Verified: | December 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Migraine Disorders Headache Disorders, Primary Headache Disorders |
Brain Diseases Central Nervous System Diseases Nervous System Diseases |

